One hundred ninety-five patients presenting with post-COVID symptomology, including
parosmia and dysgeusia, underwent reversible stellate ganglion blockade. Stellate ganglion …

Olfactory and gustatory dysfunction, including anosmia, parosmia, ageusia, and dysgeusia,
are common long-term symptoms of coronavirus disease 2019 (COVID-19) infection. These …

Background Post‐COVID parosmia may be due to dysautonomia and sympathetic
hyperresponsiveness, which can be attenuated by stellate ganglion block (SGB). This study …

Objective The objective of this study was to explore the safety and feasibility of stellate
ganglion blocks (SGBs) to treat persistent COVID‐19‐induced olfactory dysfunction (OD) …

Anosmia and parosmia refer to the loss or dysfunction of smell, respectively. Dysgeusia
refers to taste disturbance. The coronavirus disease 2019 (COVID-19) pandemic and the …

Coronavirus SARS-CoV-2 is responsible for the COVID-19 pandemic, and headache is
reported in 6.5% to 34% of all cases. There is little published evidence on the …

The SARS-CoV-2 pandemic has left millions of individuals with a host of post-viral symptoms
that can be debilitating and persist indefinitely. To date there are no definitive tests or …

Abstract According to the World Health Organization, as of September 2021, there have
been over 226.8 million people diagnosed with coronavirus disease 2019 and over 4.6 …

Purpose: Different modalities of treatment have been suggested in the treatment for post
COVID-19 olfactory dysfunction (OD). Starting with lifestyle modification, smoking cessation …

In this paper, we described technique of platelet rich plasma injection into the olfactory cleft
in a 22-year-old female with 24-month post–COVID-19 anosmia. The technique starts with …